Lexmark: The Supreme Court’s patent exhaustion case and parallel trade in drugs
Lexmark: The Supreme Court’s patent exhaustion case and parallel trade in drugs
KEI Briefing Note 2017:2. James Love. Revised 31 May 2017.
2017: GeneXion Oncology Prospective Grant of Exclusive Patent License for Mutant IDH1 Inhibitors Useful for Treating Cancer
(More on government funded inventions here. Other KEI comments on NIH licenses are found here.) On May 31, 2017, we sent the following comment to the NIH regarding the proposed exclusive license on certain patents for cancer treatment to GeneXion Oncology. May 31,… Continue Reading
KEI Statements on World Health Assembly Committee Passage of Cancer Resolution | May 30, 2017
For additional information, contact:
- James Love (+41.76.413.6854 thru Wed., May 31, 2017, and +1.202.361.3040 thereafter, james.love@keionline.org)
- Thiru Balasubramaniam (thiru@keionline.org, +41.76.508.0997)
The final text of the resolution (WHA70.12, Cancer prevention and control in the context of an integrated approach) can be found it here: http://apps.who.int/gb/ebwha/pdf_files/WHA70/A70_R12-en.pdf
WHA70: Statement of India (SEARO) on cancer prevention and control in the context of an integrated approach
On Tuesday, 30 May 2017, India, on behalf of the WHO South-East Asia Region, delivered the following intervention on Cancer prevention and control in the context of an integrated approach.
WHA 70: Statement of Knowledge Ecology International – Third High-Level Meeting of the GA on NCDs
On Tuesday, 30 May 2017, Knowledge Ecology International delivered the following intervention on Preparation for the third High-Level Meeting of the General Assembly on the Prevention and Control of Noncommunicable Diseases, to be held in 2018. The statement was delivered by Thiru Balasubramaniam.
WHA 70: Statement of Knowledge Ecology International – Global vaccine action plan
On Monday, 29 May 2017, Knowledge Ecology International delivered the following intervention on the Global vaccine action plan. The statement was delivered by James Love.
14.1 Global vaccine action planStatement:
WHA70: Statement of Portugal on the Global shortage of, and access to medicines and vaccines
Portugal delivered the following statement at the 70th World Health Assembly on agenda item, 13.3 – Global shortage of, and access to medicines and vaccines.
In relation to the Report of the United Nations High-Level Panel on Access to Medicines (UNHLP), the delegation of Portugal quoted the intervention delivered by the Portuguese Minister of Health, Professor Campos Fernandes at the plenary of the 70th World Health Assembly.
WHA70: Statement of Knowledge Ecology International – CEWG follow up
On Friday, 26 May 2017, Knowledge Ecology International delivered the following intervention on the Follow-up of the report of the Consultative Expert Working Group on Research and Development: Financing and Coordination. The statement was delivered by Thiru Balasubramaniam.
13.5 Follow-up of the report of the Consultative Expert Working Group on Research and Development: Financing and CoordinationStatement:
In May 2016, the 69th World Health Assembly (WHA) requested (WHA69.23) the Director-General:
WHA70: Statement of Knowledge Ecology International on antimicrobial resistance
On Wednesday, 24 May 2017, Knowledge Ecology International delivered the following intervention on antimicrobial resistance. This statement was read by Andrew Goldman.
KEI would like to call attention to a proposal introduced in the United States Congress, as Senate Bill 771, sponsored by 16 US Senators, and HR 1776, which has 14 sponsors in the House of Representatives.SEC. 409K of the bill is titled, “PRIZE FUND FOR NEW AND MORE EFFECTIVE TREATMENTS OF BACTERIAL INFECTIONS.”
WHA70: Statement of Knowledge Ecology International on review of the GSPOA-PHI
On Friday, 26 May 2017, Knowledge Ecology International delivered the following intervention on the Evaluation and review of the global strategy and plan of action on public health, innovation and intellectual property. This statement was read by Manon Ress.
13.4 Evaluation and review of the global strategy and plan of action on public health, innovation and intellectual propertyThe GSPOA evaluation conducted by Capra International was disappointing, raising questions about the terms of reference, and low ambition.
